Literature DB >> 33622348

Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread.

Daniel O Pinto1, Sarah Al Sharif1, Gifty Mensah1, Maria Cowen1, Pooja Khatkar1, James Erickson1, Heather Branscome1, Thomas Lattanze1, Catherine DeMarino1, Farhang Alem1, Ruben Magni2, Weidong Zhou2, Sandrine Alais3, Hélène Dutartre3, Nazira El-Hage4, Renaud Mahieux3, Lance A Liotta2, Fatah Kashanchi5.   

Abstract

BACKGROUND: The Human T-cell Lymphotropic Virus Type-1 (HTLV-1) is a blood-borne pathogen and etiological agent of Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). HTLV-1 has currently infected up to 10 million globally with highly endemic areas in Japan, Africa, the Caribbean and South America. We have previously shown that Extracellular Vesicles (EVs) enhance HTLV-1 transmission by promoting cell-cell contact.
RESULTS: Here, we separated EVs into subpopulations using differential ultracentrifugation (DUC) at speeds of 2 k (2000×g), 10 k (10,000×g), and 100 k (100,000×g) from infected cell supernatants. Proteomic analysis revealed that EVs contain the highest viral/host protein abundance in the 2 k subpopulation (2 k > 10 k > 100 k). The 2 k and 10 k populations contained viral proteins (i.e., p19 and Tax), and autophagy proteins (i.e., LC3 and p62) suggesting presence of autophagosomes as well as core histones. Interestingly, the use of 2 k EVs in an angiogenesis assay (mesenchymal stem cells + endothelial cells) caused deterioration of vascular-like-tubules. Cells commonly associated with the neurovascular unit (i.e., astrocytes, neurons, and macrophages) in the blood-brain barrier (BBB) showed that HTLV-1 EVs may induce expression of cytokines involved in migration (i.e., IL-8; 100 k > 2 k > 10 k) from astrocytes and monocyte-derived macrophages (i.e., IL-8; 2 k > 10 k). Finally, we found that EVs were able to promote cell-cell contact and viral transmission in monocytic cell-derived dendritic cell. The EVs from both 2 k and 10 k increased HTLV-1 spread in a humanized mouse model, as evidenced by an increase in proviral DNA and RNA in the Blood, Lymph Node, and Spleen.
CONCLUSIONS: Altogether, these data suggest that various EV subpopulations induce cytokine expression, tissue damage, and viral spread.

Entities:  

Year:  2021        PMID: 33622348      PMCID: PMC7901226          DOI: 10.1186/s12977-021-00550-8

Source DB:  PubMed          Journal:  Retrovirology        ISSN: 1742-4690            Impact factor:   4.602


  113 in total

1.  Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105.

Authors:  H Hirai; J Fujisawa; T Suzuki; K Ueda; M Muramatsu; A Tsuboi; N Arai; M Yoshida
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

Review 2.  The interplay between exosomes and autophagy - partners in crime.

Authors:  Jing Xu; Robert Camfield; Sharon M Gorski
Journal:  J Cell Sci       Date:  2018-08-03       Impact factor: 5.285

3.  Exosomes from uninfected cells activate transcription of latent HIV-1.

Authors:  Robert A Barclay; Angela Schwab; Catherine DeMarino; Yao Akpamagbo; Benjamin Lepene; Seble Kassaye; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2017-09-08       Impact factor: 5.157

4.  Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells.

Authors:  Heather Branscome; Siddhartha Paul; Pooja Khatkar; Yuriy Kim; Robert A Barclay; Daniel O Pinto; Dezhong Yin; Weidong Zhou; Lance A Liotta; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-24       Impact factor: 4.147

5.  Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.

Authors:  Dmitriy Mazurov; Anna Ilinskaya; Gisela Heidecker; Alexander Filatov
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

6.  The release of DNA into the plasma of mice following hepatic cell death by apoptosis and necrosis.

Authors:  Trinh T Tran; Pamela Groben; David S Pisetsky
Journal:  Biomarkers       Date:  2008-03       Impact factor: 2.658

Review 7.  HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ.

Authors:  Chou-Zen Giam; Oliver John Semmes
Journal:  Viruses       Date:  2016-06-16       Impact factor: 5.048

8.  ATL-derived exosomes modulate mesenchymal stem cells: potential role in leukemia progression.

Authors:  Jamal El-Saghir; Farah Nassar; Nadim Tawil; Marwan El-Sabban
Journal:  Retrovirology       Date:  2016-10-19       Impact factor: 4.602

9.  Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Authors:  Tadasuke Naito; Jun-Ichirou Yasunaga; Yuichi Mitobe; Kazumasa Shirai; Hiroe Sejima; Hiroshi Ushirogawa; Yuetsu Tanaka; Tatsufumi Nakamura; Kousuke Hanada; Masahiro Fujii; Masao Matsuoka; Mineki Saito
Journal:  Retrovirology       Date:  2018-11-06       Impact factor: 4.602

10.  Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.

Authors:  Vilma Urbonaviciute; Barbara G Fürnrohr; Silke Meister; Luis Munoz; Petra Heyder; Francesco De Marchis; Marco E Bianchi; Carsten Kirschning; Hermann Wagner; Angelo A Manfredi; Joachim R Kalden; Georg Schett; Patrizia Rovere-Querini; Martin Herrmann; Reinhard E Voll
Journal:  J Exp Med       Date:  2008-12-08       Impact factor: 14.307

View more
  8 in total

1.  The Expression of Tax and HBZ Genes in Serum-Derived Extracellular Vesicles From HTLV-1 Carriers Correlates to Proviral Load and Inflammatory Markers.

Authors:  Debora Glenda Lima de La-Roque; Elaine Vieira Santos; Evandra Strazza Rodrigues; Péricles Natan Mendes da Costa; Verônica Soares Brauer; Fausto Almeida; Tissiana Marques de Haes; Osvaldo Massaiti Takayanagui; Dimas Tadeu Covas; Simone Kashima
Journal:  Front Microbiol       Date:  2022-05-02       Impact factor: 6.064

2.  Plasma CD16+ Extracellular Vesicles Associate with Carotid Artery Intima-Media Thickness in HIV+ Adults on Combination Antiretroviral Therapy.

Authors:  Lishomwa C Ndhlovu; Philip J Norris; Erika G Marques de Menezes; Xutao Deng; Jocelyn Liu; Scott A Bowler; Cecilia M Shikuma; Mars Stone; Peter W Hunt
Journal:  mBio       Date:  2022-04-18       Impact factor: 7.786

3.  A Dynamic Model for Imputing Missing Medical Data: A Multiobjective Particle Swarm Optimization Algorithm.

Authors:  Peyman Almasinejad; Amin Golabpour; Mohammad Reza Mollakhalili Meybodi; Kamal Mirzaie; Ahmad Khosravi
Journal:  J Healthc Eng       Date:  2021-10-08       Impact factor: 3.822

4.  Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage.

Authors:  Heather Branscome; Pooja Khatkar; Sarah Al Sharif; Dezhong Yin; Sheela Jacob; Maria Cowen; Yuriy Kim; James Erickson; Christine A Brantner; Nazira El-Hage; Lance A Liotta; Fatah Kashanchi
Journal:  Sci Rep       Date:  2022-02-07       Impact factor: 4.379

Review 5.  Milk Transmission of HTLV-1 and the Need for Innovative Prevention Strategies.

Authors:  Sebastian Millen; Andrea K Thoma-Kress
Journal:  Front Med (Lausanne)       Date:  2022-03-11

6.  A secretory form of Parkin-independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivo.

Authors:  Marissa Howard; James Erickson; Zachary Cuba; Shawn Kim; Weidong Zhou; Purva Gade; Rachel Carter; Kelsey Mitchell; Heather Branscome; Daivik Siddhi; Fatimah Alanazi; Yuriy Kim; Robyn P Araujo; Amanda Haymond; Alessandra Luchini; Fatah Kashanchi; Lance A Liotta
Journal:  J Extracell Vesicles       Date:  2022-07

Review 7.  Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.

Authors:  Victoria Maksimova; Amanda R Panfil
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

Review 8.  The Potential of Exosomes in Allergy Immunotherapy.

Authors:  Paul Engeroff; Monique Vogel
Journal:  Vaccines (Basel)       Date:  2022-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.